Michael Wilschanski

12.7k total citations · 1 hit paper
139 papers, 6.9k citations indexed

About

Michael Wilschanski is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Michael Wilschanski has authored 139 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 48 papers in Surgery and 18 papers in Psychiatry and Mental health. Recurrent topics in Michael Wilschanski's work include Cystic Fibrosis Research Advances (84 papers), Neonatal Respiratory Health Research (33 papers) and Child Nutrition and Feeding Issues (18 papers). Michael Wilschanski is often cited by papers focused on Cystic Fibrosis Research Advances (84 papers), Neonatal Respiratory Health Research (33 papers) and Child Nutrition and Feeding Issues (18 papers). Michael Wilschanski collaborates with scholars based in Israel, United States and France. Michael Wilschanski's co-authors include Eitan Kerem, Joseph Rivlin, Batsheva Kerem, Hannah Blau, Peter R. Durie, Micha Aviram, Lea Bentur, Carla Colombo, Bernard Rudensky and Mary Corey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Michael Wilschanski

135 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis

2016 350 citations Dominique Turck, Christian Braegger et al. Clinical Nutrition profile →

Peers

Countries citing papers authored by Michael Wilschanski

Since Specialization

Citations

This map shows the geographic impact of Michael Wilschanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wilschanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wilschanski more than expected).

Fields of papers citing papers by Michael Wilschanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wilschanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wilschanski. The network helps show where Michael Wilschanski may publish in the future.

Co-authorship network of co-authors of Michael Wilschanski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wilschanski. A scholar is included among the top collaborators of Michael Wilschanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wilschanski. Michael Wilschanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-classical pulmonary exacerbation in cystic fibrosis revealing ALK-Translocated lung cancer: A case report 2025 ·Respiratory Medicine Case Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rottem Kuint, Nurith Hiller, Elie Picard, (unknown), (unknown), Michael Wilschanski, Myriam Grunewald, (unknown), Malena Cohen‐Cymberknoh	1
2	Evolution of nutritional management in children with cystic fibrosis – a narrative review 2024 ·Journal of Human Nutrition and Dietetics ·Chris Smith, (unknown), (unknown), Michael Wilschanski	2
3	Infantile-onset inflammatory bowel disease has variable long-term outcomes 2023 ·Frontiers in Pediatrics ·(unknown), (unknown), Ron Shaoul, Raffi Lev‐Tzion, (unknown), Michael Wilschanski, Aaron Lerner, Baruch Yerushalmi, Dror S. Shouval, Hussein Shamaly, (unknown), Batia Weiss	2
4	Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators 2023 ·Journal of Cystic Fibrosis ·(unknown), Malena Cohen‐Cymberknoh, Eitan Kerem, Benjamin Z. Koplewitz, Natalia Simanovsky, Michael Wilschanski, (unknown), Oded Breuer	5
5	ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis 2023 ·Clinical Nutrition ·Michael Wilschanski, À. Munck, (unknown), Marco Cipolli, Sarah Collins, Carla Colombo, Dimitri Declercq, Elpis Hatziagorou, Jessie M. Hulst, Daina Kalnins, Christina N. Katsagoni, Jochen G. Mainz, Carmen Ribes‐Koninckx, Chris Smith, Thomas J. Smith, Stéphanie Van Biervliet, Michail Chourdakis	32
6	The effect of probiotic administration on metabolomics and glucose metabolism in CF patients 2022 ·Pediatric Pulmonology ·Michal Gur, Nehama Zuckerman‐Levin, (unknown), (unknown), Luca Laghi, Massimiliano Marazzato, (unknown), Fahed Hakim, Ronen Bar‐Yoseph, Michael Wilschanski, Lea Bentur	5
7	Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era 2022 ·Current Opinion in Pulmonary Medicine ·Michael Wilschanski, D. Peckham	6
8	Initial Development and Validation of a Transition Readiness Scale for Adolescents with Inflammatory Bowel Disease 2019 ·Gastroenterology Research and Practice ·(unknown), (unknown), Dan Turner, Arie Levine, Raanan Shamir, Amit Assa, Michael Wilschanski, Yaacov G. Bachner, Eran Israeli	6
9	EPC/HPSG evidence-based guidelines for the management of pediatric pancreatitis 2018 ·Pancreatology ·Andrea Párniczky, Maisam Abu‐El‐Haija, Sohail Z. Husain, Mark E. Lowe, Grzegorz Oracz, Miklós Sahin‐Tóth, Flóra Szabó, Aliye Uç, Michael Wilschanski, Heiko Witt, László Czakó, Tassos Grammatikopoulos, Ib Rasmussen, Robert Sutton, Péter Hegyi	68
10	Obesogenic habits among children and their families in response to initiation of gluten-free diet 2018 ·European Journal of Pediatrics ·(unknown), Michael Wilschanski, (unknown), (unknown), Moti Moskovitz, (unknown), Eyal Shteyer	12
11	[RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF PEDIATRIC ACUTE GASTROENTERITIS IN ISRAEL - UPDATE 2017]. 2017 ·PubMed ·Firas Rinawi, Shai Ashkenazi, Michael Wilschanski, Eli Somekh, Raanan Shamir	3
12	ESPGHAN- Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children with Neurological Impairment. 2017 ·Journal of Pediatric Gastroenterology and Nutrition ·Carmela Romano, (unknown), Jessie M. Hulst, Ilse Broekaert, Jiří Bronský, Luigi Dall’Oglio, Nataša Fidler Mis, Iva Hojsak, Rok Orel, Argyro Papadopoulou, Michela Schaeppi, Nikhil Thapar, Michael Wilschanski, Patrick W. Sullivan, Frédèric Gottrand	4
13	ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis breakdown → 2016 ·Clinical Nutrition ·Dominique Turck, Christian Braegger, Carla Colombo, Dimitri Declercq, Alison Morton, Rouzha Pancheva, Eddy Robberecht, Martin Stern, Birgitta Strandvik, (unknown), S. Schneider, Michael Wilschanski	350
14	Definitions of Pediatric Pancreatitis and Survey of Present Clinical Practices 2012 ·Journal of Pediatric Gastroenterology and Nutrition ·Véronique D. Morinville, Sohail Z. Husain, Harrison X. Bai, Bradley Barth, Rabea Alhosh, Peter R. Durie, Steven D. Freedman, Ryan Himes, Mark E. Lowe, John F. Pohl, Steven L. Werlin, Michael Wilschanski, Aliye Uç, (unknown)	321
15	Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis 2011 ·European Respiratory Journal ·Michael Wilschanski, L.L. Miller, David Shoseyov, H. Blau, Joseph Rivlin, Micha Aviram, Michael Cohen, S. Armoni, Yasmin Yaakov, (unknown), Malena Cohen‐Cymberknoh, (unknown), A. Reha, Valerie Northcutt, Samit Hirawat, K. Donnelly, Gary Elfring, Temitayo Ajayi, Eitan Kerem	151
16	Concomitant cystic fibrosis and coeliac disease: reminder of an important clinical lesson 2009 ·BMJ Case Reports ·Malena Cohen‐Cymberknoh, Michael Wilschanski	2
17	Mutations in the Cystic Fibrosis Transmembrane Regulator Gene and *In Vivo* Transepithelial Potentials 2006 ·American Journal of Respiratory and Critical Care Medicine ·Michael Wilschanski, Annie Dupuis, Lynda Ellis, Keith Jarvi, Julian Zielenski, Elizabeth Tullis, Sheelagh Martin, Mary Corey, Lap‐Chee Tsui, Peter R. Durie	126
18	Helicobacter pylori Genotypes in Israeli Children: The Significance of Geography 2002 ·Journal of Pediatric Gastroenterology and Nutrition ·Shmuel Benenson, David Halle, Bernard Rudensky, Joseph Faber, Yechiel Schlesinger, David Branski, (unknown), Michael Wilschanski	4
19	A Pilot Study of the Effect of Gentamicin on Nasal Potential Difference Measurements in Cystic Fibrosis Patients Carrying Stop Mutations 2000 ·American Journal of Respiratory and Critical Care Medicine ·Michael Wilschanski, (unknown), Hannah Blau, Joseph Rivlin, A Augarten, Avraham Avital, Batsheva Kerem, Eitan Kerem	151
20	Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. 1996 ·Gut ·Michael Wilschanski, Philip M. Sherman, Paul B. Pencharz, Lori Davis, Mary Corey, Anne M. Griffiths	192

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact